Toogood Geoffrey
Pacemaker Clinic, Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia.
Aust Fam Physician. 2007 Jul;36(7):518-9, 521-4.
Since the first cardiac pacemaker was inserted in 1958 vast changes have occurred in both the technology of the devices and their indications.
This article discusses the indications for pacemakers, currently available devices, insertion procedure, and patient follow up.
Pacemakers have evolved from simple, single chamber devices to multichambered devices capable of treating not only bradycardias but also tachycardias and heart failure. An international classification has been developed regarding arrhythmias and the benefits of pacemakers. In class I conditions, the benefits of pacemakers are well established, decreasing symptoms and improving prognosis. The most common indications are for patients with symptomatic bradycardia associated with sick sinus syndrome and heart block. Patients need to attend for regular device follow up and be aware of precautions relating to electromagnetic radiation, but this usually involves little disruption to their day-to-day life.
自1958年首例心脏起搏器植入以来，设备技术及其适应证均发生了巨大变化。
本文讨论起搏器的适应证、现有设备、植入程序及患者随访。
起搏器已从简单的单腔设备发展为多腔设备，不仅能够治疗心动过缓，还能治疗心动过速和心力衰竭。已制定了关于心律失常及起搏器益处的国际分类。在I类情况下，起搏器的益处已得到充分证实，可减轻症状并改善预后。最常见的适应证是患有与病态窦房结综合征和心脏传导阻滞相关的症状性心动过缓的患者。患者需要定期进行设备随访，并了解与电磁辐射相关的注意事项，但这通常对其日常生活干扰很小。
Zotero 插件